The retail group returned to take part in a series B round that will find the expansion of chickpea-based protein developer InnovoPro's production capacity.

Israel-based protein product developer InnovoPro has received $15m in series B funding from investors including retail group Migros.

Venture capital firm Jerusalem Venture Partners led the round, which also featured CPT Capital, the alternative protein-focused VC fund representing the family office of Jeremy Coller, chairman of private equity firm Coller Capital.

InnovoPro has created a protein substitute made from non-genetically modified chickpeas for use in vegan products such as mayonnaise, ice cream, energy bars or veggie burgers.

The capital will…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.